Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,801 | 901 | 99.6% |
| Education | $59.67 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,927 | 189 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,723 | 83 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,400 | 146 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,027 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $996.07 | 60 | $0 (2024) |
| PFIZER INC. | $703.47 | 54 | $0 (2024) |
| Abbott Laboratories | $651.29 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $496.66 | 31 | $0 (2024) |
| Lilly USA, LLC | $484.68 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $437.00 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,948 | 90 | Novo Nordisk Inc ($238.73) |
| 2023 | $798.77 | 48 | Novo Nordisk Inc ($179.87) |
| 2022 | $1,430 | 102 | GlaxoSmithKline, LLC. ($222.84) |
| 2021 | $1,802 | 126 | Novo Nordisk Inc ($283.25) |
| 2020 | $1,638 | 126 | Novo Nordisk Inc ($366.78) |
| 2019 | $1,564 | 116 | AstraZeneca Pharmaceuticals LP ($334.26) |
| 2018 | $2,254 | 151 | Novo Nordisk Inc ($305.34) |
| 2017 | $2,428 | 149 | Janssen Pharmaceuticals, Inc ($387.56) |
All Payment Transactions
908 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: VACCINE | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.03 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Biological | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Biological | ||||||
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.81 | General |
| 09/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,281 | 4,020 | $616,102 | $270,413 |
| 2022 | 29 | 2,583 | 5,142 | $751,085 | $343,936 |
| 2021 | 28 | 2,560 | 5,119 | $742,541 | $315,772 |
| 2020 | 32 | 2,789 | 5,131 | $822,693 | $323,006 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 344 | 849 | $182,535 | $71,493 | 39.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 156 | 1,165 | $96,695 | $52,721 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 211 | 211 | $49,277 | $26,193 | 53.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 243 | $50,544 | $22,332 | 44.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 131 | 132 | $53,196 | $17,563 | 33.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 168 | 180 | $38,340 | $15,827 | 41.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 164 | $23,616 | $9,965 | 42.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 57 | $31,578 | $9,386 | 29.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 132 | 132 | $10,560 | $9,382 | 88.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $6,460 | $4,804 | 74.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 133 | 133 | $4,522 | $3,917 | 86.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 79 | $11,692 | $3,889 | 33.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 216 | 216 | $7,776 | $3,823 | 49.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 212 | 212 | $7,632 | $3,752 | 49.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 17 | $8,194 | $3,424 | 41.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 20 | 20 | $8,200 | $2,657 | 32.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $4,280 | $2,079 | 48.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $5,206 | $1,908 | 36.6% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 25 | 27 | $4,590 | $1,572 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,575 | $872.84 | 24.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 14 | $2,380 | $799.82 | 33.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,560 | $715.44 | 45.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $1,595 | $630.54 | 39.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 40 | $1,360 | $388.85 | 28.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 19 | $589.00 | $268.82 | 45.6% |
About Dr. Manav Jasrotia, MD
Dr. Manav Jasrotia, MD is a Internal Medicine healthcare provider based in Goodyear, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801993910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manav Jasrotia, MD has received a total of $13,861 in payments from pharmaceutical and medical device companies, with $1,948 received in 2024. These payments were reported across 908 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($13,801).
As a Medicare-enrolled provider, Jasrotia has provided services to 10,213 Medicare beneficiaries, totaling 19,412 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Goodyear, AZ
- Active Since 09/20/2006
- Last Updated 02/15/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801993910
Products in Payments
- Ozempic (Drug) $1,051
- XARELTO (Drug) $823.67
- TRELEGY ELLIPTA (Drug) $810.35
- FARXIGA (Drug) $578.46
- JARDIANCE (Drug) $461.48
- SYMBICORT (Drug) $409.80
- ELIQUIS (Drug) $396.22
- Rybelsus (Drug) $281.94
- CHANTIX (Drug) $264.50
- ENTRESTO (Drug) $259.54
- JANUVIA (Drug) $236.54
- STIOLTO RESPIMAT (Drug) $229.85
- TRULICITY (Drug) $224.49
- Victoza (Drug) $204.15
- BREZTRI (Drug) $199.49
- ANORO ELLIPTA (Drug) $194.61
- ANORO (Drug) $193.04
- Veozah (Drug) $191.63
- Vascepa (Drug) $173.80
- INVOKANA (Drug) $166.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Goodyear
Paramvir Sidhu, Md, MD
Internal Medicine — Payments: $34,086
Deepanshu Garg, M.d, M.D
Internal Medicine — Payments: $16,357
Dr. Sharad Chandrika, M.d, M.D
Internal Medicine — Payments: $14,448
Dr. Dat Tran, M.d, M.D
Internal Medicine — Payments: $3,570
Jared Berkowitz, M.d, M.D
Internal Medicine — Payments: $2,953
Supriya Bhardwaj, Md, MD
Internal Medicine — Payments: $2,822